{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-013536","form_type":"8-K","ticker":"STSS","cik":"0001737995","company_name":"Sharps Technology Inc.","filed_at":"2025-06-04T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.523368+00:00","generated_at":"2026-05-20T00:02:56.932401+00:00","sec_items":["7.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Sharps begins first commercial shipments; transitions to revenue-generating stage","bullets":["Initiated shipments under three customer orders; first commercial revenue from $500K total purchase commitments.","Delivered initial $400K SoloGard order under $50M supply agreement with U.S. IV solutions leader.","Shipped $100K SecureGard order to Hungarian vaccine provider; first commercial order.","Began 200K unit shipment of 1mL syringes for Botox delivery pens to Swiss injectable therapies provider.","CEO Hayes says company now a commercial-stage, revenue-generating firm after R&D and manufacturing investments."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-013536","json":"https://secwatch.observer/filing/0001641172-25-013536.json","markdown":"https://secwatch.observer/filing/0001641172-25-013536.md","text":"https://secwatch.observer/filing/0001641172-25-013536.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1737995/000164117225013536/0001641172-25-013536-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1737995/000164117225013536/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-20T00:02:56.932401+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}